Research Report

Enterprise Asset Management Market   is predicted to close in on a valuation of US$ 4.86 Bn by 2028, surging ahead at a CAGR of 7.1% from 2022 to 2028. Future Market Insights has recently published a market research report titled “Enterprise Asset Management Market – Global Industry Analysis 2014 – 2021 and Opportunity Assessment 2022 – 2028.” The growth of Artificial Intelligence (AI) and drone-based enterprise solutions are among the factors driving the enterprise asset management market. AI helps improve data handling to make better decisions. Asset visibility is an important factor for implementing the EAM system that gives accurate information on the identities, materials, and supplies. Effective asset management helps control or eliminate overstocking and stockpiling, as well as helps reduce fixed capital investments. EAM software offers more robust analytical systems for managing assets, preventative maintenance, and workflow analysis. EAM Is Rapidly Integrating with

  A new study of Future Market Insights (FMI) estimates the global spending on  clinical trials   in 2019 at ~US$ 95 Bn , recording a ~4% Y-o-Y over 2018. The healthcare sector is closing in on a new era of clinical trials, which are more engaged with patients, streamlined and connected. With development costs reaching record highs and patents approaching cliffs, companies are strengthening their R&D efforts to keep pace with change. Medical device and pharma giants are already eyeing better approaches for clinical trials, implementing a combination of their current systems and better technologies to ebb challenges in critical areas – orphan drugs and rare diseases. According to the study, the clinical trials landscape is witnessing  a paradigm shift toward patient centricity , in a bid to incorporate perspective of patients during the clinical trial design. Clinical trial sponsors have aligned their methods with the voice of patients, by launching communication channels

  The Thoracic Surgery Equipments Market holds nearly 10% of the US$ 12 Bn cancer surgery market in 2021. The global Lung Cancer Surgery Market was valued at US$ 1.23 Bn in 2021 and is expected to reach US$ 1.98 Bn by 2029, finds Future Market Insights (FMI) in a recent market survey. Lung cancer refers to the growth of abnormal cells in the lung tissue. Non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) are the two major types of lung cancer. Treatment options for lung cancer usually includes various types of therapies such as chemotherapy, radiation therapy, immunotherapy, targeted drug therapy and surgery. Attempts to cure the disease with surgery involve the removal of the tumour, the surrounding lung tissue, and lymph nodes in the tumour area. Surgery is considered the treatment of choice for localized cancer, including carcinoid tumours. The rising level of air pollution in developing economies and the increasing research and development activities on c

  The Lung Cancer Surgical Equipments Market holds nearly 10% of the US$ 12 Bn cancer surgery market in 2021. The global Lung Cancer Surgery Market was valued at US$ 1.23 Bn in 2021 and is expected to reach US$ 1.98 Bn by 2029, finds Future Market Insights (FMI) in a recent market survey. Lung cancer refers to the growth of abnormal cells in the lung tissue. Non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) are the two major types of lung cancer. Treatment options for lung cancer usually includes various types of therapies such as chemotherapy, radiation therapy, immunotherapy, targeted drug therapy and surgery. Attempts to cure the disease with surgery involve the removal of the tumour, the surrounding lung tissue, and lymph nodes in the tumour area. Surgery is considered the treatment of choice for localized cancer, including carcinoid tumours. The rising level of air pollution in developing economies and the increasing research and development activities

  The Minimally Invasive Lung Cancer Surgery holds nearly 10% of the US$ 12 Bn cancer surgery market in 2021. The global Lung Cancer Surgery Market was valued at US$ 1.23 Bn in 2021 and is expected to reach US$ 1.98 Bn by 2029, finds Future Market Insights (FMI) in a recent market survey. Lung cancer refers to the growth of abnormal cells in the lung tissue. Non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) are the two major types of lung cancer. Treatment options for lung cancer usually includes various types of therapies such as chemotherapy, radiation therapy, immunotherapy, targeted drug therapy and surgery. Attempts to cure the disease with surgery involve the removal of the tumour, the surrounding lung tissue, and lymph nodes in the tumour area. Surgery is considered the treatment of choice for localized cancer, including carcinoid tumours. The rising level of air pollution in developing economies and the increasing research and development activities

    The global Thoracotomy Lung Cancer Surgery was valued at US$ 1.23 Bn in 2021 and is expected to reach US$ 1.98 Bn by 2029, finds Future Market Insights (FMI) in a recent market survey. Lung cancer refers to the growth of abnormal cells in the lung tissue. Non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC) are the two major types of lung cancer. Treatment options for lung cancer usually includes various types of therapies such as chemotherapy, radiation therapy, immunotherapy, targeted drug therapy and surgery.   Attempts to cure the disease with surgery involve the removal of the tumour, the surrounding lung tissue, and lymph nodes in the tumour area. Surgery is considered the treatment of choice for localized cancer, including carcinoid tumours. The rising level of air pollution in developing economies and the increasing research and development activities on cancer treatment are some of the major trends bolstering the market outlook. The National Canc

  Annually billions of dollars are being spent on pharmaceuticals, vaccines and feed additives to protect animals from a wide range of diseases. Rising demand for animal pharmaceuticals and vaccines will therefore continue to boost the growth of Veterinary healthcare market during the forecast period.   The animal healthcare market is valued at US$ 42.3 Billion in 2021. The market is likely to grow at a CAGR of 4.3% through 2027, reaching US$ 54.5 Billion by 2027. Improving animal health has become a top priority for people and governments across the world, as they play a vital role in maintaining the balance of the ecosystem.     Similarly, large amounts are being spent on purchasing animal feed additives to improve animal health and enhance their immune system. Rapid expansion of animal feed additives market will therefore continue to facilitate the growth of animal healthcare industry. The   feed additive segment is expected to grow at 4.6% CAGR through 2027, reaching aroun

    Annually billions of dollars are being spent on pharmaceuticals, vaccines and feed additives to protect animals from a wide range of diseases. Rising demand for animal pharmaceuticals and vaccines will therefore continue to boost the growth of Demand for Animal Pharmaceuticals during the forecast period.   The animal healthcare market is valued at US$ 42.3 Billion in 2021. The market is likely to grow at a CAGR of 4.3% through 2027, reaching US$ 54.5 Billion by 2027. Improving animal health has become a top priority for people and governments across the world, as they play a vital role in maintaining the balance of the ecosystem.     Similarly, large amounts are being spent on purchasing animal feed additives to improve animal health and enhance their immune system. Rapid expansion of animal feed additives market will therefore continue to facilitate the growth of animal healthcare industry. The   feed additive segment is expected to grow at 4.6% CAGR through 2027, reach

  Annually billions of dollars are being spent on pharmaceuticals, vaccines and feed additives to protect animals from a wide range of diseases. Rising demand for animal pharmaceuticals and vaccines will therefore continue to boost the growth of Animal Feed Additives Market during the forecast period. The animal healthcare market is valued at US$ 42.3 Billion in 2021. The market is likely to grow at a CAGR of 4.3% through 2027, reaching US$ 54.5 Billion by 2027.Improving animal health has become a top priority for people and governments across the world, as they play a vital role in maintaining the balance of the ecosystem.   Similarly, large amounts are being spent on purchasing animal feed additives to improve animal health and enhance their immune system. Rapid expansion of animal feed additives market will therefore continue to facilitate the growth of animal healthcare industry. The   feed additive segment is expected to grow at 4.6% CAGR through 2027, reaching around US$ 25.